View Older Stories View More Recent Stories
-
Exelixis to Webcast Fireside Chats as Part of Investor Conferences in May
-
Viracta Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference
-
Avid Bioservices to Participate at Upcoming Investor Conferences
-
Xenon Pharmaceuticals to Present at the 2024 RBC Capital Markets Global Healthcare Conference
-
InvestorNewsBreaks – Vistagen Therapeutics Inc. (NASDAQ: VTGN) to Present at Upcoming RBC Capital Markets Global Healthcare Conference
-
Intra-Cellular Therapies (ITCI) PT Lowered to $96 at RBC Capital
-
Community Health Systems to Participate in 2024 RBC Capital Markets Global Healthcare Conference
-
Ventas (VTR) PT Raised to $52 at RBC Capital, 'backdrop should drive solid earnings growth'
-
Welltower, Inc. (WELL) PT Raised to $101 at RBC Capital, 'continues to deliver solid operating results'
-
HealthEquity Sets Date to Announce First Quarter Results
-
Neogen® to Participate in 2024 RBC Capital Markets Global Healthcare Conference
-
Vistagen to Present at the 2024 RBC Capital Markets Global Healthcare Conference
-
Wave Life Sciences to Present at 2024 RBC Capital Markets Global Healthcare Conference
-
RBC Capital on Atkore (ATKR): 'We would expect the selling pressure to be bracketed'
-
Pacira BioSciences to Participate in Fireside Chat at the 2024 RBC Capital Markets Global Healthcare Conference
-
Datadog, Inc. (DDOG) tops earnings, revenue expectations but stock drops
-
Baby Bunting Group Ltd (BBN:AU) RBC Capital Starts Baby Bunting Group Ltd (BBN:AU) at Sector Perform
-
RBC on Datadog (DDOG): 'stock is down ~10% in premarket trading as the stock has been strong YTD vs peers'
-
ServiceNow (NOW) analyst day prompts positive reactions
-
Verastem Oncology to Present at the RBC Capital Markets Global Healthcare Conference
-
Repligen Corporation to Present at Upcoming May Investor Conferences
-
Knight to Present at the 2024 RBC Capital Markets Global Healthcare Conference in New York City
-
uniQure Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress
-
Truist completes previously announced sale of Truist Insurance Holdings to investor group led by Stone Point Capital and CD&R
-
Applied Therapeutics to Present at the 2024 RBC Capital Markets Global Healthcare Conference
-
Nurix Therapeutics to Participate in RBC Capital Markets Global Healthcare Conference
-
BioCryst to Present at Upcoming Investor Conferences
-
Tylenol maker Kenvue to cut 4% jobs, beats quarterly profit estimates
-
Design Therapeutics to Participate in the 2024 RBC Capital Markets Global Healthcare Conference
-
Vistra Energy (VST) PT Raised to $95 at RBC Capital
-
Vertex (VRTX) PT Raised to $424 at RBC Capital
-
Varonis Systems (VRNS) PT Raised to $58 at RBC Capital
-
Universal Health Services (UHS) PT Raised to $189 at RBC Capital
-
Teradata (TDC) PT Lowered to $44 at RBC Capital
-
Pliant Therapeutics (PLRX) PT Lowered to $45 at RBC Capital
-
Palantir Technologies Inc. (PLTR) PT Raised to $9 at RBC Capital
-
Huntsman (HUN) PT Raised to $26 at RBC Capital
-
Fidelity National Information Services (FIS) PT Raised to $82 at RBC Capital
-
Crown Castle (CCI) PT Lowered to $100 at RBC Capital
-
Constellation Energy (CEG) PT Raised to $211 at RBC Capital
-
Ares Management, L.P. (ARES) PT Raised to $150 at RBC Capital
-
Archrock (AROC) PT Raised to $22 at RBC Capital
-
Aurinia Will Attend 2024 RBC Capital Markets Global Healthcare Conference
-
Infrastructure Dividend Split Corp. Files Final Prospectus
-
Genesis Energy (GEL) Prices Upsized $700M Notes Offering
-
Genesis Energy, L.P. Upsizes and Prices Public Offering of Senior Notes
-
Ares Capital (ARCC) Prices $850M Notes Offering
-
Ares Capital Corporation Prices Public Offering of $850 Million 5.950% Unsecured Notes Due 2029
-
OptimizeRx to Participate in Upcoming Investor Conferences
-
Palantir raises 2024 forecast on robust AI demand, but falls short of lofty expectations
